Published in J Virol on April 01, 2000
Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber. EMBO J (2002) 2.06
Reovirus induces and benefits from an integrated cellular stress response. J Virol (2006) 1.74
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol (2001) 1.43
Virion disassembly is required for apoptosis induced by reovirus. J Virol (2002) 1.40
The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J Virol (2010) 1.38
Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest (2005) 1.34
Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol (2000) 1.31
Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J Virol (2007) 1.24
Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain. PLoS Pathog (2008) 1.19
Targeting cancer-initiating cells with oncolytic viruses. Mol Ther (2009) 1.18
Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J Virol (2001) 1.18
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J Virol (2004) 1.07
Reovirus receptors and pathogenesis. J Virol (2003) 1.04
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Mol Cancer (2011) 1.04
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus. J Virol (2006) 1.02
Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells. J Infect Dis (2008) 1.02
REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors. Invest New Drugs (2012) 1.02
From touchdown to transcription: the reovirus cell entry pathway. Curr Top Microbiol Immunol (2010) 1.01
Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol (2003) 1.00
JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis. J Virol (2006) 1.00
Retracted Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol (2005) 1.00
Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol (2006) 0.99
Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog (2010) 0.98
Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol (2009) 0.97
Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol (2005) 0.95
Inhibition of NF-kappa B activity and cFLIP expression contribute to viral-induced apoptosis. Apoptosis (2005) 0.95
Reovirus activates a caspase-independent cell death pathway. MBio (2013) 0.95
Novel nuclear herniations induced by nuclear localization of a viral protein. J Virol (2004) 0.95
Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp Neurol (2005) 0.94
Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation. Br J Cancer (2011) 0.94
Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa. J Virol (2011) 0.93
Nonstructural protein of infectious bursal disease virus inhibits apoptosis at the early stage of virus infection. J Virol (2006) 0.93
Gene expression in the brain during reovirus encephalitis. J Neurovirol (2010) 0.92
Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B. Aging (Albany NY) (2009) 0.92
Mechanisms of apoptosis during reovirus infection. Curr Top Microbiol Immunol (2005) 0.92
Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. J Virol (2002) 0.91
Oncolytic reovirus in canine mast cell tumor. PLoS One (2013) 0.88
Directional release of reovirus from the apical surface of polarized endothelial cells. MBio (2013) 0.88
Interferon regulatory factor 3 attenuates reovirus myocarditis and contributes to viral clearance. J Virol (2010) 0.88
Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate. Virol J (2010) 0.86
Reovirus receptors, cell entry, and proapoptotic signaling. Adv Exp Med Biol (2013) 0.84
Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation. J Virol (2001) 0.82
Apoptosis induction influences reovirus replication and virulence in newborn mice. J Virol (2013) 0.81
Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells. Front Oncol (2014) 0.80
Quercetin 7-rhamnoside reduces porcine epidemic diarrhea virus replication via independent pathway of viral induced reactive oxygen species. Virol J (2011) 0.79
An ITAM in a nonenveloped virus regulates activation of NF-κB, induction of beta interferon, and viral spread. J Virol (2013) 0.79
Oncolytic virus therapy for cancer. Oncolytic Virother (2013) 0.78
Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus. Viruses (2015) 0.78
The oncolytic effects of reovirus in canine solid tumor cell lines. J Vet Med Sci (2015) 0.77
Viral gene expression potentiates reovirus-induced necrosis. Virology (2015) 0.77
Reovirus μ1 Protein Affects Infectivity by Altering Virus-Receptor Interactions. J Virol (2016) 0.76
Genes Induced by Reovirus Infection Have a Distinct Modular Cis-Regulatory Architecture. Curr Genomics (2005) 0.76
Viral RNA at two stages of reovirus infection is required for the induction of necroptosis. J Virol (2017) 0.75
PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer. PLoS One (2017) 0.75
NF-κB activation is cell type-specific in the heart. Virology (2016) 0.75
Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity. Pediatr Surg Int (2017) 0.75
Death receptors: signaling and modulation. Science (1998) 16.95
I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (1988) 16.40
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell (1994) 11.62
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
Polypeptide components of virions, top component and cores of reovirus type 3. Virology (1969) 9.83
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev (1995) 9.31
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell (1990) 9.24
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell (1995) 8.80
Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science (1995) 8.75
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev (1995) 7.36
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature (1988) 7.35
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev (1992) 5.67
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev (1989) 5.61
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol (1995) 5.32
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science (1988) 4.77
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
Viruses and apoptosis. Curr Opin Genet Dev (1995) 3.26
Programmed cell death in the immune system. Adv Immunol (1991) 3.02
Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci U S A (1997) 2.81
Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74
Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc Natl Acad Sci U S A (1985) 2.15
Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol (1995) 2.14
Apoptosis in viral infections. Adv Virus Res (1995) 1.97
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol (1997) 1.88
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol Today (1989) 1.82
Viruses and apoptosis. J Gen Virol (1998) 1.80
NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem (1994) 1.73
Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol (1996) 1.71
Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol (1995) 1.62
Apoptosis: an overview. Br Med Bull (1997) 1.61
The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol (1997) 1.59
Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol (1997) 1.58
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science (1995) 1.50
High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell (1993) 1.45
The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J Virol (1996) 1.43
Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol (1978) 1.32
Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J Immunol Methods (1996) 1.32
Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol (1999) 1.30
Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol (1997) 1.29
Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology (1999) 1.25
Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a sigma1s-null mutant. J Virol (1998) 1.17
Biosynthesis of reovirus-specified polypeptides: the reovirus s1 mRNA encodes two primary translation products. Virology (1985) 1.14
Modulation of cellular signals by calpain. Ann N Y Acad Sci (1992) 1.02
The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE). Genomics (1994) 0.99
Site-directed activation of calpain is promoted by a membrane-associated natural activator protein. Biochem J (1993) 0.96
Molecular biology of HTLV-I: recent progress. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.95
High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells. J Virol (1999) 0.95
Identification and partial purification of a factor that stimulates calcium-dependent proteases. Biochemistry (1982) 0.88
Purification and characterization of a calpain activator from human platelets. Biochem Biophys Res Commun (1992) 0.85
Selective reovirus infection of murine hepatocarcinoma cells during cell division. A model of viral liver infection. J Clin Invest (1994) 0.85
Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B. Int Immunol (1996) 0.85
Interaction of HTLV-I Tax with the human proteasome: implications for NF-kappa B induction. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.85
Immunolocalization of cytoplasmic and myelin mcalpain in transfected Schwann cells: I. Effect of treatment with growth factors. J Neurosci Res (1997) 0.84
A new structural class of proteasome inhibitors that prevent NF-kappa B activation. Biochem Pharmacol (1998) 0.81
Immunolocalization of cytoplasmic and myelin mcalpain in transfected Schwann cells: II. Effect of withdrawal of growth factors. J Neurosci Res (1997) 0.78
Expression of transcription factor genes after influenza A virus infection. Immunobiology (1997) 0.78
NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science (1993) 9.03
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell (1988) 5.33
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol (1995) 5.32
Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. Nucleic Acids Res (1979) 4.74
Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A (1997) 4.07
Junction adhesion molecule is a receptor for reovirus. Cell (2001) 4.00
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science (1989) 3.48
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J (1993) 3.28
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell (1992) 3.25
A new global mode of Earth deformation: seasonal cycle detected. Science (2001) 3.03
Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc Natl Acad Sci U S A (1989) 3.00
Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature (1998) 2.89
Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc Natl Acad Sci U S A (1994) 2.79
NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci U S A (1990) 2.75
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
c-rel activates but v-rel suppresses transcription from kappa B sites. Proc Natl Acad Sci U S A (1991) 2.65
Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med (1986) 2.62
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell (1992) 2.53
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Myonecrosis and myofibrosis as complications of sickle cell anemia. Ann Intern Med (1991) 2.35
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci U S A (1992) 2.29
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J Exp Med (2000) 2.25
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol (1995) 2.14
Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem (2000) 2.12
Employment status, employment conditions, and limiting illness: prospective evidence from the British household panel survey 1991-2001. J Epidemiol Community Health (2004) 2.06
MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A (2000) 2.04
Genetic organization of the region encoding regulation, biosynthesis, and transport of rhizobactin 1021, a siderophore produced by Sinorhizobium meliloti. J Bacteriol (2001) 1.97
Molecular basis of viral neurotropism: experimental reovirus infection. Neurology (1985) 1.94
Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) (1982) 1.91
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Mutational analysis of the immunoglobulin heavy chain promoter region. Proc Natl Acad Sci U S A (1986) 1.89
Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. J Exp Med (1997) 1.85
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol Today (1989) 1.82
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med (1989) 1.78
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc Natl Acad Sci U S A (1988) 1.74
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood (1999) 1.73
Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol (1990) 1.71
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases. Oncogene (1999) 1.68
Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J Virol (1995) 1.68
An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex. Proteins (1991) 1.66
Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol (1997) 1.66
A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med (2003) 1.66
Home blood-glucose measurements without reflectance meter. Lancet (1980) 1.65
Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol (2000) 1.64
Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB. Mol Cell Biol (1996) 1.64
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J (1999) 1.61
Efficacy study of video-assisted thoracoscopic surgery pleurodesis for spontaneous pneumothorax. Ann Thorac Surg (2001) 1.59
IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J Biol Chem (1999) 1.57
Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg (1995) 1.55
Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol (1998) 1.53
Clinical analysis of isolated angiitis of the central nervous system. A report of 11 cases. Arch Intern Med (1991) 1.51
Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem (1992) 1.50
Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol (1997) 1.50
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J Virol (1989) 1.49
Human T lymphocyte genetic modification with naked DNA. Mol Ther (2000) 1.47
Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes. J Virol (1996) 1.46
Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol (1993) 1.46
Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin. Br J Dermatol (1997) 1.45
Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency. Mol Cell Biol (1994) 1.45
Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol (2001) 1.43
The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkappaB kinases containing IKKalpha and IKKbeta. J Biol Chem (1998) 1.42
Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg (2001) 1.42
A reexamination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis Rheum (1995) 1.41
Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell (2001) 1.40
A national survey of nurse practitioner chlamydia knowledge and treatment practices of female patients. Nurse Pract (1996) 1.40
Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem (1990) 1.40
A reexamination of the relationship between myositis and malignancy. J Rheumatol (1991) 1.38
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing). J Virol (1986) 1.38
Murine polypyrimidine tract binding protein. Purification, cloning, and mapping of the RNA binding domain. J Biol Chem (1991) 1.37
Tumor necrosis factor-alpha activation of the IL-2 receptor-alpha gene involves the induction of kappa B-specific DNA binding proteins. J Immunol (1989) 1.37
Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J Biol Chem (1995) 1.37
A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther (1993) 1.33
Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med (2000) 1.33
Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product. Mol Cell Biol (1996) 1.33
Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol (1993) 1.33
Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol (2000) 1.31
Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol (1999) 1.30
Reovirus sigmaNS protein is required for nucleation of viral assembly complexes and formation of viral inclusions. J Virol (2001) 1.29
Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ (2002) 1.29